发明名称 |
Compositions for inhibiting immune complex formation in a subject |
摘要 |
Polypeptides and other compounds that can bind specifically to the CH2-CH3 cleft of an immunoglobulin molecule, and methods for using such polypeptides and compounds to inhibit Fc-mediated immune complex formation, are described. |
申请公布号 |
US9447145(B2) |
申请公布日期 |
2016.09.20 |
申请号 |
US201313751428 |
申请日期 |
2013.01.28 |
申请人 |
Trinity Therapeutics, Inc. |
发明人 |
Bodie Neil M.;Altman Elliot |
分类号 |
C07K7/08;C07K14/47;A61K38/00 |
主分类号 |
C07K7/08 |
代理机构 |
Fish & Richardson P.C. |
代理人 |
Fish & Richardson P.C. |
主权项 |
1. A composition comprising a pharmaceutically acceptable carrier and a polypeptide that comprises the amino acid sequence Cys-Ala-Xaa-His-Leu-Gly-Glu-Leu-Val-Trp-Cys-Thr (SEQ ID NO:8), wherein the Xaa in SEQ ID NO:8 is Trp, Tyr, or Phe, wherein administration of said composition to a subject in need thereof reduces immune complex formation in said subject, wherein the polypeptide further comprises a terminal stabilizing group at the amino-terminal end, wherein the terminal stabilizing group is a tripeptide having the amino acid sequence Xaa-Pro-Pro, wherein the Xaa in the terminal stabilizing group is any amino acid, and wherein the terminal stabilizing group facilitates survival of the polypeptide in vivo. |
地址 |
Agoura Hills CA US |